Skip to content

Are you losing your hair?

Millions of men experience hair loss, impacting both confidence and self-image. If you are losing hair due to pattern hair loss (PHL), also known as androgenic alopecia, the most common form of hair loss, a new clinical trial may be able to help.

Verademics is working with doctors at ACRC Trials to investigate a new, non-hormonal, oral treatment for pattern hair loss.

Lets Grow Together!

Our clinical trial is studying a new investigational oral tablet aimed at restoring hair, without the development of sexual or heart-related side effects. If you’re a man aged 18-65 experiencing pattern hair loss, you may qualify. There is no cost to you to participate and insurance is not required. Learn about the benefits of joining this hair loss clinical trial and see if you may qualify today.

Sign Up

Why Participate

Before a medication can be approved for treatment, it must go through clinical trials to assess its safety and effectiveness.
 
Clinical trials are conducted at medical centers throughout the country and rely on volunteers like you who help doctors explore new and better treatment approaches for various conditions.
 
Participating in a clinical trial like this one, provides access to the latest research and may offer new potential treatment options for your condition.

Criteria to Qualify

  • A male between the ages of 18-65
  • Experiencing signs of pattern hair loss, such as receding hairline, thinning at the temples, and/or thinning on the crown
  • Current hair length is at least 1/4"
Sign Up

About the Study

This study is a multi-center, randomized, double-blinded, placebo-controlled, parallel group, multi-dose comparison against placebo, followed by a treatment extension.
If you qualify and are enrolled in the study, you will receive the following at no cost to you:
  • The investigational medication or a placebo* (Placebo is a pill that looks like the study drug, but contains no active ingredients)
  • All study-related care, monitoring, and hair growth evaluations
  • Compensation for time and travel may be provided
  • The study involves 13 visits to a clinical site over the course of approximately 12 months, where participants will receive the investigational treatment or placebo
  • At month 6, ALL PARTICIPANTS will receive the study medication for the remaining 6 months
  • Each visit will include health assessments and hair evaluations
  • We strive to make participation as safe, comfortable, and seamless as possible
ARC Male Androgenic Alopecia 4